Cedazuridine; Decitabine Patent Expiration

Cedazuridine; Decitabine is Used for treating patients with CDA deficiency. It was first introduced by Otsuka Pharmaceutical Co Ltd in its drug Inqovi on Jul 7, 2020.


Cedazuridine; Decitabine Patents

Given below is the list of patents protecting Cedazuridine; Decitabine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Inqovi US8268800 Certain compounds, compositions and methods Aug 22, 2030 Otsuka
Inqovi US8618075 Certain compounds, compositions and methods Oct 16, 2028 Otsuka
Inqovi US9567363 Certain compounds, compositions and methods Oct 16, 2028 Otsuka


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳